- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Synta Pharmaceuticals Corp+ Add to Watchlist
SNTA:US3.8013 USD 0.1487 3.76%
As of 11:11:47 ET on 08/01/2014.
Company Profile for Synta Pharmaceuticals Corp (SNTA)
Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.
Synta Pharmaceuticals Corp
Key Executives for Synta Pharmaceuticals Corp (SNTA)
|Keith R GollustChairman/Interim CEO||Vojo VukovicSenior VP/Chief Medical Ofcr|
|Arthur McMahon "Art"Senior VP:People Operations||Keith S EhrlichVP:Finance/CFO|
|Wendy E RiederVP:Intellectual Property/Secy||Mindy S KohlAssociate Dir:Investor Relations|